InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: HALF FULL GLASS post# 7131

Saturday, 12/02/2006 4:09:34 PM

Saturday, December 02, 2006 4:09:34 PM

Post# of 30387
Based on all the information currently available, you estimate that the patient in your office has a one in four chance of having a serious disease. You order a diagnostic test with sensitivity of 95% and specificity of 90%.

2. The result comes back positive. Based on all the information now available, the chance your patient really has the disease is closest to
a. 100%
b. 95%
c. 90%
d. 75%
e. 60%
f. roughly 30%

the answer is (d)

The new format test:
"On 68 prostate cancers (Stages I and II) the new format detected 71% of cancers with 87% specificity."

The radio-immune assay:
"RECAF cancer test detects initial stages of prostate cancer with 75% sensitivity and 100% specificity when compared to healthy individuals; and 68% sensitivity with 97% specificity when compared to men with benign prostate conditions."

I just noticed something. The latest test says it detected 71% of the cancers. That is not the sensitivity as we first read it to be. Would the sensitivity be better?




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.